Prostate cancer, the most frequently diagnosed cancer in men, primarily affects males aged 55 and older and is more common in African Americans than Caucasians. Once the cancer has metastasized, current treatments are generally ineffective. We have identified a novel anti-neoplastic agent, a specifically designed nutrient mixture (NM), containing ascorbic acid, lysine, proline and green tea extract that demonstrates a broad spectrum of anti-tumor activity against a number of human cancer cell lines. In a previous study NM significantly inhibited prostate tumor in nude mice. In this study, we tested whether the formulation exerts its anti-tumor effects through induction of apoptosis on prostate cancer cell line DU-145. The effect of the nutrient mixture (NM) on cell growth inhibition in DU-145 cells was examined by 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Morphological changes and caspase activation associated with apoptosis induction was checked by H&E staining and Live Green Caspase assay, respectively. The NM was found to be slightly toxic to DU-145 cells at 100 μg/ml, but significantly toxic at 500 μg/ml and 1000 μg/ml. Percentage of cells undergoing apoptosis also increased from 6% at 100 μg/ml to 49% at 500 μg/ml and 83% at 1000 μg/ml, with greater number of cells showing morphological changes such as condensed nuclei and an acidophilic cytoplasm at higher concentrations. For the purpose of comparison, NM was also tested on a normal human dermal fibroblast (NHDF) cell line which exhibited far less apoptosis induction as compared to DU-145 cells. The percentage of cells undergoing apoptosis in case of NHDF cells was 7% at 100 μg/ml, 25.6% at 500 μg/ml and 76.5% at 1000 μg/ml. Our results demonstrate that the NM is effective in inhibiting cancer cell viability and inducing apoptosis in prostate cancer DU-145 cells and can thus be used as an effective treatment for prostate cancer.
Several previous studies have indicated that the stromal tissue in tumors plays an indispensable role in promoting tumor growth and invasion. This is due to a reciprocal interaction and communication between the stromal and neoplastic components of tissues. Even in breast cancer cell invasion and metastases a key event has been shown to be the stimulation of fibroblasts by cancer cells to secrete enzymes such as MMPs to help degrade and modify the extracellular matrix. In this study, we investigate the in vitro and in vivo effects of two micronutrient combinations - NM1 and NM2 on the inhibition of growth and invasion of human breast cancer cell line MDA-MB-231 alone or in combination with human dermal fibroblasts (NHDF). NM1 contains ascorbic acid, lysine, proline, green tea extract and quercetin while NM2 is a combination of plant extracts such as curcumin, cruciferex, green tea extract and resveratrol. In the in vitro studies we evaluated the effect of NM1 and NM2 on several parameters such as breast cancer cell proliferation, migration and expression of matrix degrading proteases (MMPs). Treatment of NHDF with conditioned media (CM) from MDA-MB-231 cells resulted in an enhanced MMP2 enzyme expression. However, treatment with both combinations of nutrients resulted in a dose dependent reduction in the MMP2 expression to basal or lower levels. The invasion assay also showed that the invasive ability of normal fibroblasts was significantly enhanced by co-incubation with breast cancer cells in the Boyden chamber. The invasiveness was however reduced considerably upon treatment with both NM1 and NM2. A similar dose dependent inhibition in growth, invasion and migration was observed in MDA-MB-231 alone and in co-cultures. In the in vivo study, 5-6 week old mice were orthotopically inoculated with 4×106 MDA-MB-231 cells alone (Group 1) or in combination with fibroblasts (Group 2) into the mammary pad of female nude mice. Each group (n = 18) was further divided into 3 sets based on the diet: Set A was fed a regular diet; Set B was fed a diet supplemented with NM1 and Set C was fed a diet supplemented with NM2. After 6 weeks the mice were sacrificed and the tumors were excised and processed for histology. The tumor weight was recorded and it was found that NM1 and NM2 inhibited tumor weight by 42% each in group 1 and by 41% and 55% respectively in group 2. The tumor weight decreased from 1.78±0.28g in group 1A to 1.03±0.25g in group 1B and 1.03±0.12g in group 1C. Similarly, tumor weight showed a reduction from 1.64±0.19g in group 2A to 0.97±0.17g in group 2B and 0.74±0.26g in group 2C. The results suggest that both NM1 and NM2 have significant therapeutic potential in treatment of breast cancer, both through a direct suppressive effect on cancer cells and through an indirect effect of limiting cancer-stromal interactions by inhibiting communication between cancer cells and fibroblasts. Citation Format: Neha Shanker, M. Waheed Roomi, Aleksandra Niedzwiecki, Matthias Rath. Inhibition of breast cancer - fibroblast interaction by specific micronutrient combinations. [abstract]. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 3194. doi:10.1158/1538-7445.AM2015-3194
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.